Matthew Gline owns 2.29% of Roivant Sciences
16,549,136 shares as of the October 16, 2026 filing, worth $597M at the latest close.
ROIV · $26B market capGet an email when Matthew Gline’s stake moves.
Free.
The stake
2.29%
worth $597M at the latest close
Stake rank
#144
by dollar value of the stake
Last sale
194 days ago
Apr 16, 2026
Last buy
404 days ago
Sep 18, 2025 · $49,957
Matthew Gline owns 2.29% of Roivant Sciences Ltd.: 16,549,136 of 722,323,015 shares, worth about $597M at the 2026-10-26 close. The stake has moved from 0.76% in 2021 to 2.29% on 2026-10-16, across 13 sales and 1 purchase that moved it since 2016. The last trade that moved it was a discretionary sale of $8.4M on 2026-04-16.
How the stake is held
as of the Oct 16, 2026 filing
SHARES
OF THE STAKE
COMMON STOCK · stated Oct 16, 2026 · Form 4 ↗
HELD DIRECTLY
16,549,136
100.0%
THE STAKE
16,549,136
2.29%